Author + information
- Received January 24, 1989
- Revision received March 15, 1989
- Accepted April 12, 1989
- Published online October 1, 1989.
- Fayaz A. Shawl, MD, FACC∗∗,
- Mervyn B. Forman, MD, FACC†,
- Sudhakar Punja, MD, FACC† and
- Thomas S. Goldbaum, MD, FACC∗
- ↵∗Address for reprints: Fayaz A. Shawl, MD, Interventional Cardiology, Washington Adventist Hospital, 7600 Carrol Avenue, Takoma Park, Maryland 20912.
Severe mitral regurgitation in the setting of an evolving myocardial infarction is associated with a high operative mortality rate. Five patients with acute severe mitral regurgitation secondary to ischemic posterior papillary muscle dysfunction underwent emergent percutaneous transluminal coronary angioplasty. Two patients were in cardiogenic shock and required intraaortic balloon counter-pulsation. Angioplasty resulted in rapid improvement in hemodynamic variables, and all patients were discharged at a mean of 10 days after the procedure.
Long-term follow-up study (mean 35 ± 6 months) revealed normal mitral valve function angiographically and by Doppler echocardiography in four patients. Repeat angioplasty was required in one patient, and another underwent coronary artery bypass surgery without valve replacement for restenosis. One patient developed progressive mitral regurgitation and required elective mitral valve replacement 12 months after angioplasty.
These preliminary findings suggest that emergent coronary angioplasty is a useful therapeutic intervention in the treatment of ischemic mitral regurgitation and is associated with a favorable long-term outcome.
☆ Dr. Forman is a recipient of a First Award from National Institutes of Health, Bethesda, Maryland. Part of this work was presented in abstract form at the American Federation of Clinical Research, New Orleans. Louisiana, February 1986 and at the 59th Annual Scientific Session of the American Heart Association Dallas, Texas, November 1986.
- Received January 24, 1989.
- Revision received March 15, 1989.
- Accepted April 12, 1989.